institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published loading...Updated

Stem cell therapy frees diabetics from insulin

  • Vertex Pharmaceuticals presented phase 2 FORWARD study results on June 20-23, 2025, showing that 10 of 12 type 1 diabetes patients became insulin independent after receiving zimislecel in Chicago.
  • The results followed more than 25 years of research, with patients receiving a portal vein infusion of stem cell-derived islet cells plus immunosuppressive drugs to prevent immune rejection.
  • All 12 participants showed islet cell engraftment with C-peptide detected after infusion, maintained healthy glucose levels, avoided severe hypoglycemia, and 10 stopped insulin use after about six months.
  • Michael Rickels expressed optimism that the results could lead to a groundbreaking therapy, while Marlon Pragnell highlighted stem cell treatment as a highly encouraging development that could significantly improve management of type 1 diabetes.
  • The study’s success may lead to a regulatory submission next year and suggests a potential new treatment to restore insulin production and reduce hypoglycemia risks in type 1 diabetes patients.
Insights by Ground AI
Does this summary seem wrong?

70 Articles

All
Left
6
Center
17
Right
7
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 57% of the sources are Center
57% Center
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

The Globe & Mail broke the news in Canada on Friday, June 20, 2025.
Sources are mostly out of (0)